What Is Qiagen N.V. (QGEN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Qiagen N.V.'s intrinsic value is estimated at $29.47, suggesting the stock is overvalued at its current price of $41.39. With 11 out of 13 models flagging downside (-28.8% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: First Chicago targets $45.37 (+9.6%), versus Dynamic NAV at $8.08 (-80.5%). This +90.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About QGEN?
13 of 13 models are currently active for QGEN. Of these, 2 models suggest upside while 11 models suggest overvaluation. The Bayesian DCF estimates QGEN's intrinsic value at $21.76, implying -47.4% downside from the current price. See which stocks rank higher →
How Does QGEN Rank in Biological Products, (No Diagnostic Substances)?
Among 134 Biological Products, (No Diagnostic Substances) stocks, QGEN ranks #128 by Quality of Company score. CirclFi's QOC score of 2.8/10 evaluates 32 fundamental signals. A score of 2.8 signals below-average fundamentals.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Qiagen N.V. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is QGEN a Value Trap?
The Value Trap algorithm is not active for QGEN. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Qiagen N.V.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Qiagen N.V.'s fundamental quality profile registers 2.8/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +90.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every QGEN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across QGEN's 13 active models, average confidence is 23%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad